SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 331.48 |
Enterprise Value ($M) | 313.59 |
Book Value ($M) | 244.32 |
Book Value / Share | 1.46 |
Price / Book | 1.36 |
NCAV ($M) | 122.63 |
NCAV / Share | 0.73 |
Price / NCAV | 2.70 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.15 |
Return on Assets (ROA) | -0.14 |
Return on Equity (ROE) | -0.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.54 |
Current Ratio | 8.54 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 171.79 |
Assets | 293.48 |
Liabilities | 49.16 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.31 |
Operating Income | -125.47 |
Net Income | -40.22 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -84.12 |
Cash from Investing | -53.30 |
Cash from Financing | -8.36 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Apeiron Investment Group Ltd. | 20.10 | 3.72 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
176,836 | 907,437 | 19.49 | |
203,105 | 307,517 | 66.05 | |
206,466 | 246,491 | 83.76 | |
149,916 | 261,975 | 57.23 | |
(click for more detail) |
Similar Companies | |
---|---|
AQST – Aquestive Therapeutics, Inc. | ARCT – Arcturus Therapeutics Holdings Inc. |
ARDX – Ardelyx, Inc. | ATXS – Astria Therapeutics, Inc. |
AUPH – Aurinia Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io